TXS-27090-13846
3 vaccinations
1 coded response
16 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 440 / OH
- Registered
- 2021-11-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-14
Dose 1 — Moderna
-
2021-02-11
Dose 2 — Moderna
-
2021-11-13
Registered in v-safe
-
2021-11-13
Dose 3 — Pfizer-BioNTech
-
2021-11-13
Health check-in — day 0, dose 3Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-11-14
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-15
- 2021-11-16
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-20
- 2021-11-27
- 2021-12-04
- 2021-12-11
- 2021-12-18
- 2021-12-25
- 2022-02-12
-
2022-05-14
Survey response — 6 months, dose 3MedDRA: Delivery — Feeling: GoodFree text: Gave birth to a live healthy baby 5/4MedDRA releases: 2024-11 · check-in free text available
- 2022-11-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Moderna | No |
| 2 | 2021-02-11 | Moderna | No |
| 3 | 2021-11-13 | Pfizer-BioNTech | No |
Free text
Release 11 — 6 months, dose 3
Symptoms: Gave birth to a live healthy baby 5/4
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release